These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 21600232)

  • 1. Progesterone and estrogen receptor expression and activity in human non-small cell lung cancer.
    Marquez-Garban DC; Mah V; Alavi M; Maresh EL; Chen HW; Bagryanova L; Horvath S; Chia D; Garon E; Goodglick L; Pietras RJ
    Steroids; 2011 Aug; 76(9):910-20. PubMed ID: 21600232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma.
    Niikawa H; Suzuki T; Miki Y; Suzuki S; Nagasaki S; Akahira J; Honma S; Evans DB; Hayashi S; Kondo T; Sasano H
    Clin Cancer Res; 2008 Jul; 14(14):4417-26. PubMed ID: 18579664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancer.
    Siegfried JM; Farooqui M; Rothenberger NJ; Dacic S; Stabile LP
    Oncotarget; 2017 Apr; 8(15):24063-24076. PubMed ID: 28445992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells.
    Pietras RJ; Márquez DC; Chen HW; Tsai E; Weinberg O; Fishbein M
    Steroids; 2005; 70(5-7):372-81. PubMed ID: 15862820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer.
    Tirino V; Camerlingo R; Franco R; Malanga D; La Rocca A; Viglietto G; Rocco G; Pirozzi G
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):446-53. PubMed ID: 19464919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells.
    Ogba N; Manning NG; Bliesner BS; Ambler SK; Haughian JM; Pinto MP; Jedlicka P; Joensuu K; Heikkilä P; Horwitz KB
    Breast Cancer Res; 2014 Dec; 16(6):489. PubMed ID: 25475897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen.
    Stabile LP; Davis AL; Gubish CT; Hopkins TM; Luketich JD; Christie N; Finkelstein S; Siegfried JM
    Cancer Res; 2002 Apr; 62(7):2141-50. PubMed ID: 11929836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oct4 plays a crucial role in the maintenance of gefitinib-resistant lung cancer stem cells.
    Kobayashi I; Takahashi F; Nurwidya F; Nara T; Hashimoto M; Murakami A; Yagishita S; Tajima K; Hidayat M; Shimada N; Suina K; Yoshioka Y; Sasaki S; Moriyama M; Moriyama H; Takahashi K
    Biochem Biophys Res Commun; 2016 Apr; 473(1):125-132. PubMed ID: 26996130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.
    Bertolini G; Roz L; Perego P; Tortoreto M; Fontanella E; Gatti L; Pratesi G; Fabbri A; Andriani F; Tinelli S; Roz E; Caserini R; Lo Vullo S; Camerini T; Mariani L; Delia D; Calabrò E; Pastorino U; Sozzi G
    Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16281-6. PubMed ID: 19805294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progestin treatment decreases CD133+ cancer stem cell populations in endometrial cancer.
    Guy MS; Qamar L; Behbakht K; Post MD; Sheeder J; Sartorius CA; Spillman MA
    Gynecol Oncol; 2016 Mar; 140(3):518-26. PubMed ID: 26731726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor signaling pathways in human non-small cell lung cancer.
    Márquez-Garbán DC; Chen HW; Fishbein MC; Goodglick L; Pietras RJ
    Steroids; 2007 Feb; 72(2):135-43. PubMed ID: 17276470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting aromatase and estrogen signaling in human non-small cell lung cancer.
    Márquez-Garbán DC; Chen HW; Goodglick L; Fishbein MC; Pietras RJ
    Ann N Y Acad Sci; 2009 Feb; 1155():194-205. PubMed ID: 19250205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands.
    Hershberger PA; Vasquez AC; Kanterewicz B; Land S; Siegfried JM; Nichols M
    Cancer Res; 2005 Feb; 65(4):1598-605. PubMed ID: 15735050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
    Le H; Zeng F; Xu L; Liu X; Huang Y
    Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor-alpha isoforms are the main estrogen receptors expressed in non-small cell lung carcinoma.
    Pelekanou V; Anastasiou E; Bakogeorgou E; Notas G; Kampa M; Garcia-Milian R; Lavredaki K; Moustou E; Chinari G; Arapantoni P; O'Grady A; Georgoulias V; Tsapis A; Stathopoulos EN; Castanas E
    Steroids; 2019 Feb; 142():65-76. PubMed ID: 29454903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature.
    Barr MP; Gray SG; Hoffmann AC; Hilger RA; Thomale J; O'Flaherty JD; Fennell DA; Richard D; O'Leary JJ; O'Byrne KJ
    PLoS One; 2013; 8(1):e54193. PubMed ID: 23349823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enrichment and characterization of cancer stem cells from a human non-small cell lung cancer cell line.
    Zhao C; Setrerrahmane S; Xu H
    Oncol Rep; 2015 Oct; 34(4):2126-32. PubMed ID: 26239272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-expression of estrogen receptor beta and aromatase in Japanese lung cancer patients: gender-dependent clinical outcome.
    Verma MK; Miki Y; Abe K; Nagasaki S; Niikawa H; Suzuki S; Kondo T; Sasano H
    Life Sci; 2012 Oct; 91(15-16):800-8. PubMed ID: 22982181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone-inducible cytokeratin 5-positive cells in luminal breast cancer exhibit progenitor properties.
    Axlund SD; Yoo BH; Rosen RB; Schaack J; Kabos P; Labarbera DV; Sartorius CA
    Horm Cancer; 2013 Feb; 4(1):36-49. PubMed ID: 23184698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects.
    Stabile LP; Lyker JS; Gubish CT; Zhang W; Grandis JR; Siegfried JM
    Cancer Res; 2005 Feb; 65(4):1459-70. PubMed ID: 15735034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.